EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas

Irene Olaizola, Mikel Odriozola-Gimeno, Paula Olaizola, Francisco J Caballero-Camino, Noelia Pastor-Toyos, Mireia Tena-Garitaonaindia, Ainhoa Lapitz, Beatriz Val, Amanda R Guimaraes, Maitane Asensio, Maider Huici-Izagirre, Colin Rae und 18 weitere

Journal of Hepatology · 2025-11 · 83 (5) · 1077-1091

DOI: 10.1016/j.jhep.2025.04.034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatology, 2025-11. Verfasst von Irene Olaizola und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute - Donostia University Hospital -, University of the Basque C…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Cisplatin, DNA Breaks, Double-Stranded, Bile Duct Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carlos III Health Institute, Ministerio de Ciencia e Innovación, Gipuzkoa Provincial Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Patients with cholangiocarcinoma (CCA) have poor prognosis. Current cisplatin-based first-line chemotherapy offers limited survival benefit. Cisplatin induces single-strand DNA breaks, activating DNA repair mechanisms that diminish its effectiveness. Here, we present the design, chemical synthesis, and therapeutic evaluation of a new generation of chemotherapeutic agents (Aurkines) with unique polyelectrophilic properties. These agents cause a high frequency of double-strand DNA breaks, bypassing DNA repair, and promoting cancer cell death. METHODS: Two novel compounds, Aurkine 16 and Aurkine 18, were designed and evaluated for their antitumor effects in both naïve and cisplatin-resistant CCA cells, cancer-associated fibroblasts, healthy cholangiocytes, and in vivo models. RESULTS: Aurkines effectively induced double-strand DNA breaks, leading to increased DNA damage and elevated levels of reactive oxygen species, resulting in greater cytotoxicity than cisplatin in CCA cells. Phosphoproteomic and molecular analysis revealed that cisplatin activates DNA repair pathways, while Aurkines primarily induce apoptosis. Importantly, Aurkines also triggered apoptosis in cisplatin-resistant CCA cells and cancer-associated fibroblasts without harming healthy cholangiocytes. Additionally, Aurkines demonstrated cytotoxicity in other cisplatin-resistant cancers, such as breast and ovarian cancer. This tumor selectivity results from reduced uptake, increased efflux, and compact chromatin structure in normal cells, limiting Aurkine-DNA interactions. In vivo, Aurkines inhibited the growth of subcutaneous naïve and cisplatin-resistant CCA tumors, as well as orthotopic tumors in immunocompetent mice, promoting antitumor immune cell recruitment without any adverse events. Transport studies revealed that Aurkines were selectively taken up by OCT1, OCT3, CTR1, and OATP1A2, whereas only CTR1 transported cisplatin. CONCLUSIONS: Aurkines represent promising therapeutic drugs for both naïve and cisplatin-resistant cancers due to their unique polyelectrophilic properties and selective targeting of malignant cells. IMPACT AND IMPLICATIONS: This study introduces a novel therapeutic strategy designed to induce frequent double-strand DNA breaks selectively in both naïve and cisplatin-resistant cancer cells, without evident toxic side effects at therapeutic doses. This approach may form the basis for new strategies to overcome the critical challenge of drug resistance in cancer treatment and has the potential to be a breakthrough not only for the treatment of biliary tumors but also for other cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaCisplatinDNA Breaks, Double-StrandedBile Duct NeoplasmsDrug Resistance, NeoplasmAntineoplastic AgentsHumansAnimalsMiceCell Line, TumorApoptosisXenograft Model Antitumor AssaysDNA Repair

Stichwörter der Autor:innen

CancerChemoresistanceChemotherapyDNA damage

Substanzen

CisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute - Donostia University Hospital -, University of the Basque Country (UPV/EHU), Donostia-San Sebastian, Spain.
  • Department of Organic Chemistry I, Center of Innovation in Advanced Chemistry (ORFEO-CINQA), Faculty of Chemistry, University of the Basque Country (UPV/EHU) & Donostia International Physics Center (DIPC), Donostia-San…
  • Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute - Donostia University Hospital -, University of the Basque Country (UPV/EHU), Donostia-San Sebastian, Spain; National Institute fo…
  • National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, "Instituto de Salud Carlos III"), Spain; Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute of Biomedical Research of Sal…
  • School of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Polimero eta Material Aurreratuak: Fisika, Kimika eta Teknologia & Donostia International Physics Center (DIPC), Donostia-San Sebastian, Spain.

Förderung

  • Carlos III Health Institute
  • Ministerio de Ciencia e Innovación
  • Gipuzkoa Provincial Council
  • European Cooperation in Science and Technology
  • Ministerio de Economía y Competitividad
  • European Research Council
  • Junta de Castilla y León
  • UK Research and Innovation

Zitieren

APA

Olaizola, I., Odriozola-Gimeno, M., Olaizola, P., Caballero-Camino, F. J., Pastor-Toyos, N., Tena-Garitaonaindia, M., Lapitz, A., Val, B., Guimaraes, A. R., Asensio, M., Huici-Izagirre, M., Rae, C., de Sancho, D., Lopez, X., Rodrigues, P. M., Herraez, E., Briz, O., Izquierdo-Sanchez, L., Eleta-Lopez, A., …, & Banales, J. M. (2025). New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas. Journal of Hepatology, 83(5), 1077-1091. https://doi.org/10.1016/j.jhep.2025.04.034

Vancouver

Olaizola I, Odriozola-Gimeno M, Olaizola P, Caballero-Camino FJ, Pastor-Toyos N, Tena-Garitaonaindia M, et al. New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas. Journal of Hepatology. 2025;83(5):1077-1091. doi:10.1016/j.jhep.2025.04.034

BibTeX
@article{Olaizola2025,
  author = {Olaizola, Irene and Odriozola-Gimeno, Mikel and Olaizola, Paula and Caballero-Camino, Francisco J and Pastor-Toyos, Noelia and Tena-Garitaonaindia, Mireia and Lapitz, Ainhoa and Val, Beatriz and Guimaraes, Amanda R and Asensio, Maitane and Huici-Izagirre, Maider and Rae, Colin and de Sancho, David and Lopez, Xabier and Rodrigues, Pedro M and Herraez, Elisa and Briz, Oscar and Izquierdo-Sanchez, Laura and Eleta-Lopez, Aitziber and Bittner, Alexander M and Martinez-Amesti, Ana and Miranda, Teresa and Ilyas, Sumera I and Braconi, Chiara and Perugorria, Maria J and Bujanda, Luis and Rivilla, Iván and Marin, Jose J G and Cossío, Fernando P and Banales, Jesus M},
  title = {New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas},
  journal = {Journal of Hepatology},
  year = {2025},
  volume = {83},
  number = {5},
  pages = {1077--1091},
  doi = {10.1016/j.jhep.2025.04.034}
}
Kostenlos starten →